Papers - NIIOKA Takenori
-
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma
Numakura Kazuyuki, Igarashi Ryoma, Takahashi Makoto, Nara Taketoshi, Kanda Sohei, Saito Mitsuru, Narita Shintaro, Inoue Takamitsu, Niioka Takenori, Miura Masatomo, Habuchi Tomonori
CANCER BIOLOGY & THERAPY 25 ( 1 ) 2312602 2024.12
-
Noninvasive Computed Tomography-Based Deep Learning Model Predicts In Vitro Chemosensitivity Assay Results in Pancreatic Cancer.
Taishu Kanda, Taiichi Wakiya, Keinosuke Ishido, Norihisa Kimura, Hayato Nagase, Eri Yoshida, Junichi Nakagawa, Masashi Matsuzaka, Takenori Niioka, Yoshihiro Sasaki, Kenichi Hakamada
Pancreas 53 ( 1 ) e55 - e61 2024.1
-
Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy.
Junichi Nakagawa, Takenori Takahata, Yu Chen, Kensuke Saito, Kosuke Kamata, Takuto Tachita, Satoru Yamashita, Keigo Saito, Kayo Ueno, Atsushi Sato, Hirotake Sakuraba, Takenori Niioka
Cancer chemotherapy and pharmacology 92 ( 5 ) 391 - 398 2023.8
-
Associations among Plasma Concentrations of Edoxaban and M-4, Prothrombin Time, and the SLCO1B1*15 Haplotype in Patients With Nonvalvular Atrial Fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Naoya Aiuchi, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
Therapeutic drug monitoring 45 ( 3 ) 409 - 416 2023.6
-
Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Naoya Aiuchi, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
European journal of clinical pharmacology 79 ( 5 ) 703 - 705 2023.5
-
服薬に対するネガティブな意識が服薬アドヒアランスに及ぼす影響 岩木健康増進プロジェクト健診調査報告
工藤 正純, 今 良仁, 横山 智士, 金澤 佐知子, 小原 信一, 細井 一広, 照井 一史, 中川 潤一, 阿保 成慶, 津山 博匡, 兵藤 塁, 相内 尚也, 世永 早紀, 畑山 昂大, 川口 聖也, 伊藤 梢, 島田 美智子, 金城 育代[成田], 井原 一成, 中路 重之, 新岡 丈典
医薬品相互作用研究 47 ( 1 ) 10 - 18 2023.3
-
Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers.
Satoshi Yokoyama, Junichi Nakagawa, Masakiyo Kudo, Naoya Aiuchi, Tatsuya Seito, Mizuri Isida, Tatsuya Mikami, Kazushige Ihara, Shigeyuki Nakaji, Takenori Niioka
Pharmacology research & perspectives 11 ( 1 ) e01048 2023.2
-
Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Naoya Aiuchi, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
European journal of clinical pharmacology 79 ( 1 ) 127 - 135 2023.1
-
Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
Satoshi Yokoyama, Junichi Nakagawa, Naoya Aiuchi, Tatsuya Seito, Takenori Niioka
Journal of clinical pharmacy and therapeutics 47 ( 9 ) 1409 - 1417 2022.9
-
Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole.
Naoya Aiuchi, Junichi Nakagawa, Hirotake Sakuraba, Takenori Takahata, Kosuke Kamata, Norihiro Saito, Kayo Ueno, Masahiro Ishiyama, Kazufumi Yamagata, Hiroyuki Kayaba, Takenori Niioka
Pharmacology research & perspectives 10 ( 2 ) e00935 2022.4
-
免疫抑制剤TDM実施において考慮すべき点
三浦 昌朋, 見野 靖晃, 本間 真人, 新岡 丈典, 竹内 裕紀
日本臨床腎移植学会雑誌 9 ( 2 ) 149 - 156 2021.12
-
Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Mei Iizuka, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
Basic & clinical pharmacology & toxicology 128 ( 2 ) 297 - 304 2021.2
-
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy.
Junichi Nakagawa, Takenori Takahata, Rui Hyodo, Yu Chen, Kengo Hasui, Kota Sasaki, Kensuke Saito, Kayo Ueno, Kazuhiro Hosoi, Kazufumi Terui, Atsushi Sato, Takenori Niioka
Scientific reports 11 ( 1 ) 785 - 785 2021.1
-
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.
Hisashi Tanaka, Kageaki Taima, Tomonori Makiguchi, Junichi Nakagawa, Takenori Niioka, Sadatomo Tasaka
Cancer communications (London, England) 41 ( 1 ) 83 - 87 2021.1
-
注射用抗がん薬使用状況調査に基づく医療費削減のためのdrug vial optimization実施方法に関する検討
照井 一史, 兵藤 塁, 中川 潤一, 細井 一広, 小原 信一, 本間 聖明, 明石 真弓, 佐藤 和洋, 矢田 康司, 宮崎 晃臣, 田中 南美英, 神 雅昭, 中村 一成, 山本 章二, 田村 健悦, 新岡 丈典
日本病院薬剤師会雑誌 = Journal of Japanese Society of Hospital Pharmacists 56 ( 12 ) 1445 - 1451 2020.12
-
Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels.
Shinji Ota, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Miwa Satake, Yui Akemoto, Nahoko Tanaka, Rina Watanabe, Maeda Takato, Yasuhisa Murai, Kayo Ueno, Takenori Niioka, Makoto Hayakari, Yoh Ishiguro, Shinsaku Fukuda
Biochemistry and biophysics reports 24 100811 - 100811 2020.12
-
注射用抗がん薬使用状況調査に基づく医療費削減のためのdrug vial optimization実施方法に関する検討
照井 一史, 兵藤 塁, 中川 潤一, 細井 一広, 小原 信一, 本間 聖明, 明石 真弓, 佐藤 和洋, 矢田 康司, 宮崎 晃臣, 田中 南美英, 神 雅昭, 中村 一成, 山本 章二, 田村 健悦, 新岡 丈典
日本病院薬剤師会雑誌 56 ( 12 ) 1445 - 1451 2020.12
-
Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation.
Junichi Nakagawa, Keinosuke Ishido, Yuka Tono, Norihisa Kimura, Taiichi Wakiya, Yuji Okamura, Kenichi Hakamada, Takenori Niioka
European journal of drug metabolism and pharmacokinetics 45 ( 5 ) 619 - 626 2020.10
-
3系統以上の抗菌薬に耐性を示す緑膿菌サーベイランスにおけるAntibiotic Heterogeneity Indexの有用性に関する検討
東野 優花, 岡村 祐嗣, 津山 博匡, 井上 文緒, 齋藤 紀先, 萱場 広之, 新岡 丈典
日本病院薬剤師会雑誌 = Journal of Japanese Society of Hospital Pharmacists 56 ( 7 ) 791 - 796 2020.7
-
3系統以上の抗菌薬に耐性を示す緑膿菌サーベイランスにおけるAntibiotic Heterogeneity Indexの有用性に関する検討
東野 優花, 岡村 祐嗣, 津山 博匡, 井上 文緒, 齋藤 紀先, 萱場 広之, 新岡 丈典
日本病院薬剤師会雑誌 56 ( 7 ) 791 - 796 2020.7
-
Association of lenvatinib trough plasma concentrations with lenvatinib-induced toxicities in Japanese patients with thyroid cancer.
Mitsuji Nagahama, Tomoko Ozeki, Akifumi Suzuki, Kiminori Sugino, Takenori Niioka, Koichi Ito, Masatomo Miura
Medical oncology (Northwood, London, England) 36 ( 5 ) 39 - 39 2019.3
-
Phase II Clinical Trial of Lenalidomide and Dexamethasone Therapy in Japanese Elderly Patients With Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide.
Kobayashi Takahiro, Miura Masatomo, Niioka Takenori, Abumiya Maiko, Ito Fumiko, Kobayashi Isuzu, Ikeda Sho, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto
Ther Drug Monit 40 ( 3 ) 301 - 309 2018.6
-
The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma.
Kobayashi Takahiro, Miura Masatomo, Abumiya Maiko, Niioka Takenori, Kanno Shuichi, Takahashi Naoto
Ann Hematol 97 ( 6 ) 1097 - 1099 2018.6
-
Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.
Numakura Kazuyuki, Fujiyama Nobuhiro, Takahashi Makoto, Igarashi Ryoma, Tsuruta Hiroshi, Maeno Atsushi, Huang Mingguo, Saito Mitsuru, Narita Shintaro, Inoue Takamitsu, Satoh Shigeru, Tsuchiya Norihiko, Niioka Takenori, Miura Masatomo, Habuchi Tomonori
Oncotarget 9 ( 38 ) 25277 - 25284 2018.5
-
Influence of CYP3A5 genetic differences in tacrolimus on quantitative interstitial fibrosis and long-term graft function in kidney transplant recipients.
Komine Naoki, Satoh Shigeru, Saito Mitsuru, Numakura Kazuyuki, Inoue Takamitsu, Tsuruta Hiroshi, Narita Shintaro, Komatsuda Atsushi, Nanjo Hiroshi, Kagaya Hideaki, Niioka Takenori, Miura Masatomo, Mitobe Yoko, Habuchi Tomonori
Int Immunopharmacol 58 57 - 63 2018.5
-
Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients.
Kagaya Hideaki, Niioka Takenori, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Yamamoto Ryohei, Akamine Yumiko, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Int J Mol Sci 19 ( 3 ) 2018.3
-
Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.
Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomonori
Med Oncol 35 ( 4 ) 51 - 51 2018.3
-
Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia.
Mita Akiko, Abumiya Maiko, Miura Masatomo, Niioka Takenori, Takahashi Saori, Yoshioka Tomoko, Kameoka Yoshihiro, Takahashi Naoto
Exp Hematol Oncol 7 9 - 9 2018
-
Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes.
Niioka Takenori, Fujishima Naohito, Abumiya Maiko, Yamashita Takaya, Ubukawa Kumi, Nara Miho, Fujishima Masumi, Takahashi Naoto, Miura Masatomo
Ther Drug Monit 39 ( 5 ) 514 - 521 2017.10
-
Effect of hepatic drug transporter polymorphisms on the pharmacokinetics of mycophenolic acid in patients with severe renal dysfunction before renal transplantation.
Kagaya Hideaki, Niioka Takenori, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Xenobiotica 47 ( 10 ) 916 - 922 2017.10
-
Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations.
Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Yamamoto Ryohei, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Clin Exp Nephrol 21 ( 5 ) 787 - 796 2017.10
-
Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival.
Okuda Yuji, Sato Kazuhiro, Sudo Kazuhisa, Hasegawa Yukiyasu, Asano Mariko, Miura Hajime, Takeda Masahide, Sano Masaaki, Watanabe Hiroyuki, Kobayashi Hiroyuki, Niioka Takenori, Miura Masatomo, Ito Hiroshi
Cancer Chemother Pharmacol 79 ( 5 ) 1013 - 1020 2017.5
-
Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib.
Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomonori
Anticancer Drugs 28 ( 1 ) 97 - 103 2017.1
-
Quantification of Interstitial Fibrosis in Renal Allografts and Clinical Correlates of Long-Term Graft Function.
Nara Mizuho, Komatsuda Atsushi, Numakura Kazuyuki, Saito Mitsuru, Inoue Takamitsu, Niioka Takenori, Miura Masatomo, Mitobe Yoko, Okuyama Shin, Takahashi Naoto, Habuchi Tomonori, Satoh Shigeru
Am J Nephrol 46 ( 3 ) 187 - 194 2017
-
Therapeutic drug monitoring enables safe and effective lenalidomide therapy in patients with multiple myeloma on hemodialysis.
Kobayashi Takahiro, Niioka Takenori, Miura Masatomo, Takahashi Naoto
Ann Hematol 95 ( 12 ) 2087 - 2088 2016.12
-
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
Yamashita Takaya, Fujishima Naohito, Miura Masatomo, Niioka Takenori, Abumiya Maiko, Shinohara Yoshinori, Ubukawa Kumi, Nara Miho, Fujishima Masumi, Kameoka Yoshihiro, Tagawa Hiroyuki, Hirokawa Makoto, Takahashi Naoto
Cancer Chemother Pharmacol 78 ( 1 ) 111 - 118 2016.7
-
Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib.
Kobayashi Hiroyuki, Sato Kazuhiro, Niioka Takenori, Takeda Masahide, Okuda Yuji, Asano Mariko, Ito Hiroshi, Miura Masatomo
Med Oncol 33 ( 6 ) 57 - 57 2016.6
-
Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patients.
Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Yamamoto Ryohei, Akamine Yumiko, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Int J Urol 23 ( 6 ) 484 - 490 2016.6
-
Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease.
Togashi Masaru, Niioka Takenori, Komatsuda Atsushi, Nara Mizuho, Okuyama Shin, Omokawa Ayumi, Abumiya Maiko, Wakui Hideki, Takahashi Naoto, Miura Masatomo
Eur J Clin Pharmacol 71 ( 9 ) 1091 - 1097 2015.9
-
Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer.
Kobayashi Hiroyuki, Sato Kazuhiro, Niioka Takenori, Miura Hajime, Ito Hiroshi, Miura Masatomo
Clin Lung Cancer 16 ( 4 ) 274 - 281 2015.7
-
Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation.
Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Inoue Takamitsu, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru, Miura Masatomo
Int J Mol Sci 16 ( 1 ) 1840 - 1854 2015.1
-
Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis.
Niioka Takenori, Komatsuda Atsushi, Kato Shotaro, Togashi Masaru, Okuyama Shin, Omokawa Ayumi, Nara Mizuho, Wakui Hideki, Takahashi Naoto, Miura Masatomo
Xenobiotica 45 ( 12 ) 1147 - 1153 2015
-
Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantation.
Numakura Kazuyuki, Kagaya Hideaki, Yamamoto Ryohei, Komine Naoki, Saito Mitsuru, Hiroshi Tsuruta, Akihama Susumu, Inoue Takamitsu, Narita Shintaro, Tsuchiya Norihiko, Habuchi Tomonori, Niioka Takenori, Miura Masatomo, Satoh Shigeru
Dis Markers 2015 179434 - 179434 2015
-
Pharmacokinetic and CYP3A5 pharmacogenetic differences between once- and twice-daily tacrolimus from the first dosing day to 1 year after renal transplantation.
Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Numakura Kazuyuki, Inoue Takamitsu, Saito Mitsuru, Komine Naoki, Narita Shintaro, Tsuchiya Norihiko, Habuchi Tomonori, Miura Masatomo
Pharmacogenomics 15 ( 11 ) 1495 - 1506 2014.8
-
A limited sampling model to estimate exposure to lenalidomide in multiple myeloma patients.
Shida Seiji, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Matsumoto Morio, Hagihara Masao, Kobayashi Takahiro, Abumiya Maiko, Kameoka Yoshihiro, Fujishima Naohito, Tagawa Hiroyuki, Hirokawa Makoto, Sawada Kenichi
Ther Drug Monit 36 ( 4 ) 505 - 509 2014.8
-
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib.
Takahashi Naoto, Miura Masatomo, Kuroki Jun, Mitani Kinuko, Kitabayashi Atsushi, Sasaki Osamu, Kimura Hideo, Imai Kiyotoshi, Tsukamoto Norifumi, Noji Hideyoshi, Kondo Takeshi, Motegi Mutsuhito, Kato Yuichi, Mita Masayuki, Saito Hajime, Yoshida Chikashi, Torimoto Yoshihiro, Kimura Tomofumi, Wano Yuji, Nomura Jun, Yamamoto Satoshi, Mayama Ko, Honma Riko, Sugawara Tomohiro, Sato Shinji, Shinagawa Atsushi, Abumiya Maiko, Niioka Takenori, Harigae Hideo, Sawada Kenichi
Biomark Res 2 ( 1 ) 6 - 6 2014.3
-
A limited sampling strategy for estimation of the area under the plasma concentration-time curve of gefitinib.
Miura Masatomo, Sato Kazuhiro, Miura Hajime, Niioka Takenori, Kobayashi Hiroyuki, Narita Chihiro, Ito Hiroshi
Ther Drug Monit 36 ( 1 ) 24 - 29 2014.2
-
Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
Hinai Y, Motoyama S, Niioka T, Miura M
J Clin Pharm Ther 38 ( 6 ) 498 - 503 2013.12
-
Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.
Niioka Takenori, Kagaya Hideaki, Miura Masatomo, Numakura Kazuyuki, Saito Mitsuru, Inoue Takamitsu, Habuchi Tomonori, Satoh Shigeru
Eur J Clin Pharmacol 69 ( 9 ) 1659 - 1665 2013.9
-
A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction.
Shinohara Yoshinori, Takahashi Naoto, Nishiwaki Kaichi, Hino Masayuki, Kashimura Makoto, Wakita Hisashi, Hatano Yoshiaki, Hirasawa Akira, Nakagawa Yasuaki, Itoh Kuniaki, Masuoka Hidekazu, Aotsuka Nobuyuki, Matsuura Yasuhiro, Takahara Sinobu, Sano Koji, Kuroki Jun, Hata Tomoko, Nakamae Hirohisa, Mugitani Atsuko, Nakane Takahiko, Miyazaki Yasushi, Niioka Takenori, Miura Masatomo, Sawada Kenichi
Haematologica 98 ( 9 ) 1407 - 1413 2013.9
-
Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
Nara Miho, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Kagaya Hideaki, Fujishima Naohito, Saitoh Hirobumi, Kameoka Yoshihiro, Tagawa Hiroyuki, Hirokawa Makoto, Sawada Kenichi
Eur J Clin Pharmacol 69 ( 6 ) 1321 - 1329 2013.6
-
A limited sampling strategy to estimate the area under the concentration-time curve of tacrolimus modified-release once-daily preparation in renal transplant recipients.
Niioka Takenori, Miura Masatomo, Kagaya Hideaki, Saito Mitsuru, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru
Ther Drug Monit 35 ( 2 ) 228 - 232 2013.4
-
Study on improvement of the accuracy and precision of predicted plasma concentration of vancomycin in the administration planning support for children
Itagaki Shirou, Hayakari Makoto, Kudo Masakiyo, Niioka Takenori, Uchiyama Michiko, Kanazawa Sachiko, Hosoi Kazuhiro, Terui Kazufumi, Kojima Keiya, Yasujima Minoru
Hirosaki Medical Journal 64 ( 1 ) 58 - 64 2013
-
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
Niioka Takenori, Satoh Shigeru, Kagaya Hideaki, Numakura Kazuyuki, Inoue Takamitsu, Saito Mitsuru, Narita Shintaro, Tsuchiya Norihiko, Habuchi Tomonori, Miura Masatomo
Transplantation 94 ( 10 ) 1013 - 1019 2012.11
-
H2-receptor antagonist influences dasatinib pharmacokinetics in a patient with Philadelphia-positive acute lymphoblastic leukemia.
Matsuoka Akihito, Takahashi Naoto, Miura Masatomo, Niioka Takenori, Kawakami Kimihiro, Matsunaga Takuya, Sawada Kenichi
Cancer Chemother Pharmacol 70 ( 2 ) 351 - 352 2012.8
-
Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation.
Takahashi Naoto, Miura Masatomo, Scott Stuart A, Niioka Takenori, Sawada Kenichi
J Hematol Oncol 5 23 - 23 2012.5
-
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
Saruwatari Junji, Yasui-Furukori Norio, Niioka Takenori, Akamine Yumiko, Takashima Ayaka, Kaneko Sunao, Uno Tsukasa
J Clin Psychopharmacol 32 ( 2 ) 195 - 199 2012.4
-
Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi Naoto, Miura Masatomo, Niioka Takenori, Sawada Kenichi
Cancer Chemother Pharmacol 69 ( 4 ) 999 - 1004 2012.4
-
Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.
Kagaya Hideaki, Miura Masatomo, Niioka Takenori, Saito Mitsuru, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru
Antimicrob Agents Chemother 56 ( 2 ) 825 - 829 2012.2
-
Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation.
Miura Masatomo, Niioka Takenori, Kato Shoutaro, Kagaya Hideaki, Saito Mitsuru, Habuchi Tomonori, Satoh Shigeru
Ther Drug Monit 33 ( 3 ) 295 - 302 2011.6
-
Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation.
Miura M, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Satoh S
J Clin Pharm Ther 36 ( 2 ) 208 - 216 2011.4
-
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.
Niioka Takenori
Yakugaku Zasshi 131 ( 3 ) 407 - 413 2011.3
-
Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.
Miura Masatomo, Motoyama Satoru, Hinai Yudai, Niioka Takenori, Endo Masahiro, Hayakari Makoto, Ogawa Jun-ichi
Xenobiotica 40 ( 9 ) 630 - 636 2010.9
-
Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration.
Miura Masatomo, Motoyama Satoru, Hinai Yudai, Niioka Takenori, Hayakari Makoto, Ogawa Jun-ichi, Suzuki Toshio
Chirality 22 ( 7 ) 635 - 640 2010.7
-
Optimal Dose of Levofloxacin in Elderly Patients with Streptococcus Pneumoniae Infection Based on Monte Carlo Simulation
Okamura Yuji, Niioka Takenori, Kimura Masahiko, Yasujima Minoru, Hayakari Makoto
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 36 ( 8 ) 592 - 598 2010
-
CYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysis.
Niioka Takenori, Uno Tsukasa
J Clin Pharm Ther 34 ( 5 ) 611 - 612 2009.10
-
Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
Miura Masatomo, Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Hayakari Makoto, Habuchi Tomonori, Suzuki Toshio
Ther Drug Monit 31 ( 4 ) 467 - 474 2009.8
-
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.
Fujii Akira, Yasui-Furukori Norio, Nakagami Taku, Niioka Takenori, Saito Manabu, Sato Yasushi, Kaneko Sunao
Drug Des Devel Ther 2 139 - 144 2009.2
-
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.
Niioka Takenori, Miura Masatomo, Uno Tsukasa, Yasui-Furukori Norio, Hayakari Makoto, Tateishi Tomonori, Suzuki Toshio
Eur J Clin Pharmacol 64 ( 5 ) 503 - 509 2008.5
-
Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
Miura Masatomo, Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Hayakari Makoto, Habuchi Tomonori, Suzuki Toshio
Ther Drug Monit 30 ( 1 ) 52 - 59 2008.2
-
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
Niioka Takenori, Uno Tsukasa, Sugimoto Katsuyoshi, Sugawara Kazunobu, Hayakari Makoto, Tateishi Tomonori
Eur J Clin Pharmacol 63 ( 11 ) 1031 - 1038 2007.11
-
Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
Uno Tsukasa, Niioka Takenori, Hayakari Makoto, Sugawara Kazunobu, Tateishi Tomonori
Ther Drug Monit 29 ( 3 ) 333 - 339 2007.6
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.
Yasui-Furukori Norio, Saito Manabu, Nakagami Taku, Niioka Takenori, Sato Yasushi, Fujii Akira, Kaneko Sunao
Psychiatry Clin Neurosci 61 ( 3 ) 308 - 312 2007.6
-
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka Takenori, Uno Tsukasa, Yasui-Furukori Norio, Takahata Takenori, Shimizu Mikiko, Sugawara Kazunobu, Tateishi Tomonori
Cancer Chemother Pharmacol 59 ( 5 ) 575 - 580 2007.4
-
Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.
Yasui-Furukori Norio, Saito Manabu, Niioka Takenori, Inoue Yoshimasa, Sato Yasushi, Kaneko Sunao
Ther Drug Monit 29 ( 1 ) 45 - 48 2007.2
-
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
Uno Tsukasa, Niioka Takenori, Hayakari Makoto, Yasui-Furukori Norio, Sugawara Kazunobu, Tateishi Tomonori
Eur J Clin Pharmacol 63 ( 2 ) 143 - 149 2007.2
-
Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.
Yasui-Furukori Norio, Saito Manabu, Inoue Yoshimasa, Niioka Takenori, Sato Yasushi, Tsuchimine Shoko, Kaneko Sunao
Eur J Clin Pharmacol 63 ( 1 ) 51 - 56 2007.1
-
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.
Niioka Takenori, Uno Tsukasa, Yasui-Furukori Norio, Shimizu Mikiko, Sugawara Kazunobu, Tateishi Tomonori
Eur J Clin Pharmacol 62 ( 10 ) 855 - 861 2006.10
-
Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve.
Niioka Takenori, Yasui-Furukori Norio, Uno Tsukasa, Sugawara Kazunobu, Kaneko Sunao, Tateishi Tomonori
Ther Drug Monit 28 ( 3 ) 321 - 325 2006.6
-
Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
Shimizu Mikiko, Uno Tsukasa, Niioka Takenori, Yaui-Furukori Norio, Takahata Takenori, Sugawara Kazunobu, Tateishi Tomonori
J Chromatogr B Analyt Technol Biomed Life Sci 832 ( 2 ) 241 - 248 2006.3
-
Hepatic clearance improves after angioplasty of the hepatic vein.
Narumi S, Hakamada K, Toyoki Y, Totsuka E, Niioka T, Umehara Y, Ono H, Nishimura A, Yoshihara S, Sasaki M
Transplant Proc 36 ( 10 ) 3091 - 3092 2004.12
-
消化器外科領域における至適抗菌剤使用に関する検討
鳴海 俊治, 新岡 丈典, 袴田 健一, 吉原 秀一, 小田桐 弘毅, 川崎 仁司, 十束 英志, 豊木 嘉一, 森田 隆幸, 佐々木 睦男
日本消化器外科学会雑誌 36 ( 7 ) 2003.7
-
Relation between Kidney Function and Use Trend of Renal Excreted Agents on Inpatients of Digestive Organ Surgery in Hirosaki University Hospital
NIIOKA Takenori, TAKEUCHI Hiroyuki, NARUMI Shunji, KAWASAKI Hitoshi, HAKAMADA Kenichi, ODAGIRI Hiroki, MORITA Takayuki, SASAKI Mutsuo, SATO Junya, SUGAWARA Kazunobu
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 27 ( 4 ) 399 - 405 2001.8